Drug intelligence / Profile preview

UIC201601

Development stage: Unknown
Lead developer: Korea United Pharm
Modality: Small Molecules

Overview

UIC201601 is an investigational small molecule drug that has been studied in early-phase clinical trials, primarily for its safety and pharmacokinetics. It has been evaluated in healthy male volunteers, including studies assessing potential drug-drug interactions with another investigational agent, UIC201602. The precise mechanism of action and therapeutic indication for UIC201601 have not been publicly disclosed as of the latest available data. There is no evidence of regulatory approval or advanced clinical development for any specific disease.

Beyond the preview

Go deeper on UIC201601.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UIC201601.

Explore the full profile